Clinical Trial Update: A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% [Phase 4]

View source ↗

Summary

A Phase 4 prospective study comparing Dexycu to Prednisolone Acetate 1% in cataract patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dexycu (dexamethasone intraocular suspension)
• Prednisolone Acetate 1% (prednisolone acetate)

Snippet

Sponsor: Research Insight LLC | Conditions: Cataract | Phase 4 | Status: COMPLETED